International Journal of Hematology and Oncology
2021, Vol 31, Num 1 Page(s): 019-027
Back | Table of Contents | Abstract | PDF | Mail to Author | |
Clinical Outcomes of CML Patients After Delayed Start of Nilotinib Treatment
Erna ISLAMAGIC1, Azra HASIC1, Sabira KURTOVIC2, Damir SULJEVIC1, Mirza KOZARIC3, Izet EMINOVIC1, Amina KURTOVIC-KOZARIC4
1University of Sarajevo, Faculty of Science, Department of Biochemistry and Physiology, BOSNIA and HERZEGOWINA
2Clinical Center of the University of Sarajevo, Department of Hematology, BOSNIA and HERZEGOWINA
3Clinical Center of the University of Sarajevo, Department of Obstetrics and Gynecology, BOSNIA and HERZEGOWINA
4Clinical Center of the University of Sarajevo, Department of Pathology, Cytology and Human Genetics, Sarajevo, BOSNIA and HERZEGOWINA
Erna ISLAMAGIC1, Azra HASIC1, Sabira KURTOVIC2, Damir SULJEVIC1, Mirza KOZARIC3, Izet EMINOVIC1, Amina KURTOVIC-KOZARIC4
1University of Sarajevo, Faculty of Science, Department of Biochemistry and Physiology, BOSNIA and HERZEGOWINA
2Clinical Center of the University of Sarajevo, Department of Hematology, BOSNIA and HERZEGOWINA
3Clinical Center of the University of Sarajevo, Department of Obstetrics and Gynecology, BOSNIA and HERZEGOWINA
4Clinical Center of the University of Sarajevo, Department of Pathology, Cytology and Human Genetics, Sarajevo, BOSNIA and HERZEGOWINA
Back | Table of Contents | Abstract | PDF | Mail to Author | |